Machine Learning Gene Signature to Metastatic ccRCC Based on ceRNA Network
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25084214 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Epitácio Farias und 2 weiteren Autor:innen. Beteiligte Einrichtung: Bioinformatics Multidisciplinary Environment (BioME), Federal University of Rio Grande do Norte (UFRN), Natal 59078-400, Brazil. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Gene Regulatory Networks, Machine Learning, Gene Expression Regulation, Neoplastic. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 106 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Coordenação de Aperfeicoamento de Pessoal de Nível Superior, Brazilian funding agency CAPES—National Coordination of High Education Personnel Formation Program.
Abstract (Originalsprache)
Clear-cell renal-cell carcinoma (ccRCC) is a silent-development pathology with a high rate of metastasis in patients. The activity of coding genes in metastatic progression is well known. New studies evaluate the association with non-coding genes, such as competitive endogenous RNA (ceRNA). This study aims to build a ceRNA network and a gene signature for ccRCC associated with metastatic development and analyze their biological functions. Using data from The Cancer Genome Atlas (TCGA), we constructed the ceRNA network with differentially expressed genes, assembled nine preliminary gene signatures from eight feature selection techniques, and evaluated the classification metrics to choose a final signature. After that, we performed a genomic analysis, a risk analysis, and a functional annotation analysis. We present an 11-gene signature: SNHG15, AF117829.1, hsa-miR-130a-3p, hsa-mir-381-3p, BTBD11, INSR, HECW2, RFLNB, PTTG1, HMMR, and RASD1. It was possible to assess the generalization of the signature using an external dataset from the International Cancer Genome Consortium (ICGC-RECA), which showed an Area Under the Curve of 81.5%. The genomic analysis identified the signature participants on chromosomes with highly mutated regions. The hsa-miR-130a-3p, AF117829.1, hsa-miR-381-3p, and PTTG1 were significantly related to the patient’s survival and metastatic development. Additionally, functional annotation resulted in relevant pathways for tumor development and cell cycle control, such as RNA polymerase II transcription regulation and cell control. The gene signature analysis within the ceRNA network, with literature evidence, suggests that the lncRNAs act as “sponges” upon the microRNAs (miRNAs). Therefore, this gene signature presents coding and non-coding genes and could act as potential biomarkers for a better understanding of ccRCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Bioinformatics Multidisciplinary Environment (BioME), Federal University of Rio Grande do Norte (UFRN), Natal 59078-400, Brazil.
- Metropolis Digital Institute (IMD), Federal University of Rio Grande do Norte (UFRN), Natal 59078-400, Brazil.
- Biomedical Engineering Department, Center of Technology, Federal University of Rio Grande do Norte (UFRN), Natal 59078-970, Brazil.
ORCID-Profile: Epitácio Farias, Patrick Terrematte, Beatriz Stransky
Förderung
- Coordenação de Aperfeicoamento de Pessoal de Nível Superior
- Brazilian funding agency CAPES—National Coordination of High Education Personnel Formation Program
Zitieren
APA
Farias, E., Terrematte, P., & Stransky, B. (2024). Machine Learning Gene Signature to Metastatic ccRCC Based on ceRNA Network. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25084214
Vancouver
Farias E, Terrematte P, Stransky B. Machine Learning Gene Signature to Metastatic ccRCC Based on ceRNA Network. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25084214
BibTeX
@article{Farias2024,
author = {Farias, Epitácio and Terrematte, Patrick and Stransky, Beatriz},
title = {Machine Learning Gene Signature to Metastatic ccRCC Based on ceRNA Network},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25084214}
}
EUVIMED